Omeprazole, Prilosec, Nexium Control (omeprazole) is a small molecule pharmaceutical. Omeprazole was first approved as Omeprazole on 1989-09-14. It is used to treat duodenal ulcer, esophagitis, gastroesophageal reflux, heartburn, and helicobacter infections amongst others in the USA. It has been approved in Europe to treat gastroesophageal reflux. The pharmaceutical is active against potassium-transporting ATPase alpha chain 1. In addition, it is known to target chloride channel protein 2. Omeprazole's patents are valid until 2036-12-08 (FDA).
|Trade Name||Nexium Control|
|Indication||duodenal ulcer, esophagitis, gastroesophageal reflux, heartburn, helicobacter infections, stomach ulcer, zollinger-ellison syndrome|
|Drug Class||Antiulcer agents (benzimidazole derivatives)|